ReVision Optics Inc. has announced the appointment of Frank Shields to the newly created position of vice president of sales worldwide. Shields will be responsible for leading the commercialization of the Raindrop Near Vision Inlay for presbyopia in the U.S. and for expanding international sales. Shields brings more than 25 years of experience in surgical sales at leading ophthalmic companies and has been instrumental in the launch of several leading ophthalmic lens products. The Raindrop Inlay, a microscopic hydrogel inlay designed to correct presbyopia, received FDA approval in late June and is also approved in the European Union, South Korea, Australia and New Zealand. “We are pleased to attract a highly talented professional like Frank to head our sales organization as we shift more focus to commercial operations,” said John Kilcoyne, ReVision Optics president and chief executive officer. “Frank has proven time and again his ability to successfully build sales teams and execute on strategies that produce results. He has first-hand experience in ophthalmic product launches and an established network of key opinion leaders. We are confident that Frank brings the expertise, vision and enthusiasm to lead our U.S. launch and grow sales in international markets.” “This is truly an exciting opportunity and I look forward to working with the team at ReVision Optics to make the Raindrop Inlay a success,” said Shields. ReVision Optics Inc. focuses on the development and commercialization of optical solutions dedicated to presbyopic vision correction. The company’s Raindrop Near Vision Inlay offers a patented refractive surgery solution for improving near vision that has been lost through the eye’s natural aging process.